Atlas Venture Fund XII, L.P.
SEC CIK 1812049 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| JBIO | Jade Biosciences, Inc. | 10% | 2.33M | $7.50M | — | 4 | 2021-07-02 | 2022-07-15 |
Most active insiders at JBIO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Balta Elizabeth | See Remarks | — | — |
| 2 | Frohlich Tom | CEO, Dir | — | — |
| 3 | King Andrew James | See Remarks | — | — |
| 4 | Dahms Bradford D. | CFO | — | — |
| 5 | Fairmount Healthcare Fund II L.P. | Dir, 10% | — | — |
Atlas Venture Fund XII, L.P. made no open-market trades at JBIO in the last 12 months.
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-07-19 | 2022-07-15 | JBIO | Jade Biosciences, Inc. | Atlas Venture Fund XII, L.P. | 10% | J - Other | $0.00 | -310.4K | 2.33M | -12% | $0 | |
| 2022-04-04 | 2022-04-01 | JBIO | Jade Biosciences, Inc. | Atlas Venture Fund XII, L.P. | 10% | J - Other | $0.00 | -465.6K | 2.64M | -15% | $0 | |
| D | 2021-07-06 | 2021-07-02 | JBIO | Jade Biosciences, Inc. | Atlas Venture Fund XII, L.P. | 10% | P - Purchase | $14.00 | +535.7K | 3.10M | +21% | +$7.50M |
| D | 2021-07-06 | 2021-07-02 | JBIO | Jade Biosciences, Inc. | Atlas Venture Fund XII, L.P. | 10% | C - Cnv Deriv | — | +2.57M | 2.57M | New | — |
Purchase Sale Sale after option exercise All abbreviations